Charles Schwab Investment Management Inc Fulgent Genetics, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 299,404 shares of FLGT stock, worth $6.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,404

Previous 243,979 22.72%

Holding current value

$6.76 Million

Previous $4.12 Million 44.36%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$16.86 - $21.81 $934,465 - $1.21 Million	55,425 Added 22.72%	299,404 $5.95 Million
Q1 2025 Sep 15, 2025	SELL	$15.28 - $18.95 $846,894 - $1.05 Million	-55,425 Reduced 18.51%	243,979 $4.12 Million
Q1 2025 May 09, 2025	BUY	$15.28 - $18.95 $515,975 - $639,903	33,768 Added 16.06%	243,979 $4.12 Million
Q4 2024 Feb 06, 2025	SELL	$16.71 - $22.68 $584,465 - $793,278	-34,977 Reduced 14.27%	210,211 $3.88 Million
Q3 2024 Nov 12, 2024	SELL	$19.6 - $25.06 $471,732 - $603,144	-24,068 Reduced 8.94%	245,188 $5.33 Million
Q2 2024 Aug 12, 2024	SELL	$19.09 - $22.57 $490,307 - $579,687	-25,684 Reduced 8.71%	269,256 $5.28 Million
Q1 2024 May 08, 2024	BUY	$21.55 - $29.29 $595,361 - $809,194	27,627 Added 10.34%	294,940 $6.4 Million
Q4 2023 Feb 06, 2024	BUY	$23.64 - $30.27 $783,453 - $1 Million	33,141 Added 14.15%	267,313 $7.73 Million
Q3 2023 Nov 08, 2023	BUY	$26.74 - $40.81 $879,077 - $1.34 Million	32,875 Added 16.33%	234,172 $6.26 Million
Q2 2023 Aug 09, 2023	BUY	$28.52 - $40.7 $618,627 - $882,823	21,691 Added 12.08%	201,297 $7.45 Million
Q1 2023 May 11, 2023	BUY	$29.39 - $36.27 $906,093 - $1.12 Million	30,830 Added 20.72%	179,606 $5.61 Million
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $42,178 - $58,124	-1,443 Reduced 0.96%	148,776 $4.43 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $230,022 - $386,646	6,066 Added 4.21%	150,219 $5.73 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $6,189 - $8,094	129 Added 0.09%	144,153 $7.86 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $187,984 - $362,430	3,771 Added 2.69%	144,024 $8.99 Million
Q4 2021 Feb 11, 2022	SELL	$77.3 - $105.0 $538,703 - $731,745	-6,969 Reduced 4.73%	140,253 $14.1 Million
Q3 2021 Nov 16, 2021	BUY	$74.87 - $110.87 $1.48 Million - $2.19 Million	19,795 Added 15.53%	147,222 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $1.07 Million - $1.61 Million	16,044 Added 14.4%	127,427 $11.8 Million
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $1.45 Million - $4.49 Million	24,441 Added 28.11%	111,383 $10.8 Million
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $440,776 - $740,549	14,214 Added 19.54%	86,942 $4.53 Million
Q3 2020 Nov 13, 2020	BUY	$15.89 - $50.51 $737,057 - $2.34 Million	46,385 Added 176.08%	72,728 $2.91 Million
Q2 2020 Aug 14, 2020	BUY	$8.89 - $18.28 $234,189 - $481,550	26,343 New	26,343 $422,000

Others Institutions Holding FLGT

# of Institutions

185

Shares Held

18.4M

Call Options Held

185K

Put Options Held

24.8K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $683M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Fulgent Genetics, Inc. Transaction History